Bill
Bill > H1056
summary
Introduced
02/16/2023
02/16/2023
In Committee
02/16/2023
02/16/2023
Crossed Over
Passed
Dead
12/31/2024
12/31/2024
Introduced Session
193rd General Court
Bill Summary
Relative to maximum allowable costs lists utilized by payers and pharmaceutical benefit managers to identify the maximum amount health plans will pay for certain prescription drugs. Financial Services.
AI Summary
This bill establishes a special commission to investigate the use of maximum allowable costs (MAC) lists by payers and pharmaceutical benefit managers (PBMs). The commission will review current practices surrounding the determination and use of MAC lists, as well as their financial implications, industry-wide standardization, and transparency in the processes of developing and utilizing these lists. The commission will consist of 10 members, including representatives from the government, health plans, pharmacists, and advocates for healthcare providers, pharmaceutical companies, and PBMs. The commission will submit its report and findings, along with any draft legislation, to the relevant legislative committees within 180 days of the passage of this act.
Committee Categories
Business and Industry
Sponsors (7)
Brad Jones (R)*,
Jay Barrows (R),
Nick Boldyga (R),
Angelo D'Emilia (R),
Kim Ferguson (R),
Hannah Kane (R),
Kelly Pease (R),
Last Action
Accompanied a study order, see H4691 (on 05/30/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/193/H1056 |
| BillText | https://malegislature.gov/Bills/193/H1056.pdf |
Loading...